1. Home
  2. EVO vs INVX Comparison

EVO vs INVX Comparison

Compare EVO & INVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • INVX
  • Stock Information
  • Founded
  • EVO 1993
  • INVX 2024
  • Country
  • EVO Germany
  • INVX United States
  • Employees
  • EVO N/A
  • INVX N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • INVX
  • Sector
  • EVO Health Care
  • INVX
  • Exchange
  • EVO Nasdaq
  • INVX NYSE
  • Market Cap
  • EVO 1.1B
  • INVX 954.4M
  • IPO Year
  • EVO 2021
  • INVX N/A
  • Fundamental
  • Price
  • EVO $5.44
  • INVX $16.27
  • Analyst Decision
  • EVO Buy
  • INVX
  • Analyst Count
  • EVO 2
  • INVX 0
  • Target Price
  • EVO $5.90
  • INVX N/A
  • AVG Volume (30 Days)
  • EVO 362.8K
  • INVX 413.8K
  • Earning Date
  • EVO 11-06-2024
  • INVX 11-07-2024
  • Dividend Yield
  • EVO N/A
  • INVX N/A
  • EPS Growth
  • EVO N/A
  • INVX 175.29
  • EPS
  • EVO N/A
  • INVX 6.87
  • Revenue
  • EVO $866,665,179.00
  • INVX $543,306,000.00
  • Revenue This Year
  • EVO $4.56
  • INVX N/A
  • Revenue Next Year
  • EVO $13.44
  • INVX $7.55
  • P/E Ratio
  • EVO N/A
  • INVX $2.37
  • Revenue Growth
  • EVO N/A
  • INVX N/A
  • 52 Week Low
  • EVO $2.85
  • INVX $13.80
  • 52 Week High
  • EVO $12.00
  • INVX $25.19
  • Technical
  • Relative Strength Index (RSI)
  • EVO 69.82
  • INVX N/A
  • Support Level
  • EVO $4.34
  • INVX N/A
  • Resistance Level
  • EVO $4.95
  • INVX N/A
  • Average True Range (ATR)
  • EVO 0.21
  • INVX 0.00
  • MACD
  • EVO 0.12
  • INVX 0.00
  • Stochastic Oscillator
  • EVO 89.72
  • INVX 0.00

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About INVX INNOVEX INTERNATIONAL INC

Innovex International Inc designs, manufactures, and installs mission-critical drilling & deployment, well construction, completion, production, and fishing & intervention solutions to support upstream onshore and offshore activities worldwide. Its comprehensive portfolio extends throughout the lifecycle of the well; and innovative product integration ensures seamless transitions from one well phase to the next, driving efficiency, lowering cost, and reducing the rig site service footprint for the customer. With locations throughout North America, Latin America, Europe, the Middle East, and Asia, The team is readily available with technical expertise, conventional and innovative technologies, and ever-present customer service.

Share on Social Networks: